Cargando…
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
In recent years, the imbalance in phosphate homeostasis in patients with end-stage renal disease (ESRD) has been the subject of much research. It appears that, while hyperphosphatemia may be a tangible indicator of deteriorating kidney function, lack of phosphate homeostasis may also be associated w...
Autores principales: | Covic, Adrian, Rastogi, Anjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728082/ https://www.ncbi.nlm.nih.gov/pubmed/23865421 http://dx.doi.org/10.1186/1471-2369-14-153 |
Ejemplares similares
-
Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?
por: Apetrii, Mugurel, et al.
Publicado: (2021) -
Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia
por: Vallée, Michel, et al.
Publicado: (2021) -
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence
por: Coyne, Daniel W., et al.
Publicado: (2022) -
Is there any link between Hyperphosphatemia, Hypoalbuminemia, and Hypocalcemia with Hospital Outcomes in COVID-19 Patients?
por: Rezaeifar, Atefeh, et al.
Publicado: (2023) -
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)